CorVel Corp. (CRVL)
NEUTRALファンダメンタル
66
株価
$69.80
時価総額
$3.61B
パート1 · 企業の価値
概要
CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing; preferred provider management and reimbursement; retrospective utilization, facility claim, and professional review; pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management customers, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
貸借対照表と流動性
売上高
$984M
直近12か月(2026/6/30まで)
純利益
$115M
直近12か月(2026/6/30まで)
フリーキャッシュフロー
$110M
自己資本合計
$394M
負債合計
$249M
流動比率
1.94
利払い倍率
-
負債/EBITDA
0.15
一株当たり利益(EPS)
売上高と純利益
フリーキャッシュフロー
収益内訳
財務推移表
利益率の推移
負債の推移
負債の重さ
成長率グリッド
成長率 — 売上高
適正価値の推定
適正価値
$26.35
現在株価
$69.80
安全マージン
-164.9%
適正価値レンジ
$21.89 - $30.80
推定方法
バリュエーション指標
P/E レシオ
31.66
ROE
28.0%
P/B レシオ
8.80
P/FCF
31.61
粗利益率
24.8%
ROIC
-
収益性レーダー
Value Creation (Economic Moat)
ROIC
-
WACC
10.3%
ROIC − WACC
-
ファンダメンタル分析基準
合格(14)
- EPS shows upward trend
- Price CAGR 19.12%
- Debt/Equity ratio
- Positive Free Cash Flow
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- Low reliance on intangibles
- ROE 29.9%
- Revenue Growth 5Y 11.6%
- Earnings Quality (OCF/NI) 1.31
- Share Dilution -0.8%
- Net Margin Trend 11.7% vs 11.0%
- Piotroski F-Score 7/9
不合格(7)
- EPS CAGR 0.24%
- Gross Margin 24.8%
- P/FCF 31.61
- P/B Ratio 8.80
- CapEx intensity
- Price below Graham Number
- DCF valuation (Overvalued)
データなし(7)
- ROIC NaN%
- Dividend Payout NaN%
- Operating Margin NaN%
- Interest Coverage
- Analyst Consensus (Finnhub)
- Earnings Surprise (no valid data)
- PEG Ratio (need PE > 0 and growth > 0)
Piotroski F-スコア
財務健全性が高い
利益の質
高品質:利益はキャッシュに裏付けられている
株式希薄化
株式を買い戻している。株主に友好的
ガバナンス
経営陣
| 氏名 | 役職 | 年齢 |
|---|---|---|
| Mr. Michael G. Combs | Executive Chair | 61 |
| Mr. Brian S. Nichols | Chief Financial Officer | 44 |
| Ms. Jennifer L. Yoss | Vice President of Accounting | 47 |
| Mr. Maxim Shishin | Chief Information Officer | 50 |
| Mr. Mark E. Bertels | Executive Vice President of Risk Management Services | 62 |
| Ms. Sarah Scott | President & CEO | 48 |
| Ms. Sharon F. O'Connor | Vice President of Legal Services | - |
| Melissa Storan | Vice President of Marketing | - |
| Jason Wheeler | Vice President of Sales & Account Management | - |
| Mr. Jeffrey D. Gurtcheff | Chief Claims Officer | - |
監査リスク
4
取締役会リスク
6
報酬リスク
5
株主権利リスク
7
パート2 · 株価と買い時
この部分は企業に価値があるかを判断するものではありません。ファンダメンタルズに納得したうえで、いつ買うかを選ぶためのものです。内容:テクニカル分析、ポテンシャル、過去のドローダウン、ガンマエクスポージャー。
Latest News
Recent headlines for CRVL, sourced from Markets Gazette.